Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics.

[1]  D. Katz,et al.  Neuroepigenetic mechanisms in disease , 2017, Epigenetics & Chromatin.

[2]  Nick C Fox,et al.  Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.

[3]  Zeran Li,et al.  CELL-TYPE PROFILING TO IDENTIFY THE TRANSCRIPTOMIC DOWNSTREAM EVENTS TRIGGERED BY EARLY-ONSET AUTOSOMAL DOMINANT AD MUTATIONS , 2017, Alzheimer's & Dementia.

[4]  K. Hao,et al.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease , 2017, Nature Neuroscience.

[5]  M. Tsolaki,et al.  Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease , 2017, Acta Neuropathologica.

[6]  Ronald C. Petersen,et al.  TYROBP genetic variants in early-onset Alzheimer's disease , 2016, Neurobiology of Aging.

[7]  David Haussler,et al.  The UCSC Genome Browser database: 2017 update , 2016, Nucleic Acids Res..

[8]  J. Buxbaum,et al.  Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer’s disease , 2016, Genome Medicine.

[9]  K. Rawlik,et al.  Imputation of DNA Methylation Levels in the Brain Implicates a Risk Factor for Parkinson’s Disease , 2016, Genetics.

[10]  Sarah A. Gagliano,et al.  Genomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases , 2016, bioRxiv.

[11]  Kristel Sleegers,et al.  Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond , 2016, The Lancet Neurology.

[12]  M. Ronaghi,et al.  Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain , 2016, Science.

[13]  O. Andreassen,et al.  Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease. , 2016, JAMA neurology.

[14]  C. Broeckhoven,et al.  Molecular genetics of early-onset Alzheimer's disease revisited , 2016, Alzheimer's & Dementia.

[15]  J. Lambert,et al.  miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer’s disease , 2016, Alzheimer's Research & Therapy.

[16]  Ben A. Barres,et al.  Complement and microglia mediate early synapse loss in Alzheimer mouse models , 2016, Science.

[17]  Michele Vendruscolo,et al.  A transcriptional signature of Alzheimer’s disease is associated with a metastable subproteome at risk for aggregation , 2016, Proceedings of the National Academy of Sciences.

[18]  Giuliano Binetti,et al.  A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer’s disease , 2016, Acta Neuropathologica.

[19]  Juan González-Vallinas,et al.  A new view of transcriptome complexity and regulation through the lens of local splicing variations , 2016, eLife.

[20]  C. Broeckhoven,et al.  Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study , 2015, The Lancet Neurology.

[21]  D. Serie,et al.  Late-onset Alzheimer disease risk variants mark brain regulatory loci , 2015, Neurology: Genetics.

[22]  Taigang He,et al.  Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer’s disease , 2015, Scientific Reports.

[23]  J. Gilbert,et al.  Alzheimer disease (AD) specific transcription, DNA methylation and splicing in twenty AD associated loci , 2015, Molecular and Cellular Neuroscience.

[24]  S. Quake,et al.  A survey of human brain transcriptome diversity at the single cell level , 2015, Proceedings of the National Academy of Sciences.

[25]  J. Schneider,et al.  Central role for PICALM in amyloid–β blood–brain barrier transcytosis and clearance , 2015, Nature Neuroscience.

[26]  Manolis Kellis,et al.  Alzheimer’s loci: epigenetic associations and interaction with genetic factors , 2015, Annals of clinical and translational neurology.

[27]  L. Tan,et al.  TYROBP in Alzheimer’s Disease , 2015, Molecular Neurobiology.

[28]  H. Stefánsson,et al.  Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease , 2015, Nature Genetics.

[29]  Manolis Kellis,et al.  Large-scale epigenome imputation improves data quality and disease variant enrichment , 2015, Nature biotechnology.

[30]  F. Edwards,et al.  A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. , 2015, Cell reports.

[31]  Juha E. Jääskeläinen,et al.  Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models , 2015, Neurobiology of Aging.

[32]  Manolis Kellis,et al.  Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease , 2015, Nature.

[33]  J. Gallacher,et al.  Convergent genetic and expression data implicate immunity in Alzheimer's disease , 2014, Alzheimer's & Dementia.

[34]  J. Satoh,et al.  A Comprehensive Profile of ChIP-Seq-Based PU.1/Spi1 Target Genes in Microglia , 2014, Gene regulation and systems biology.

[35]  L. Lue,et al.  TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post‐Mortem Temporal Cortices , 2014, Brain pathology.

[36]  Zugen Chen,et al.  Integrating Genome-Wide Association Study and Brain Expression Data Highlights Cell Adhesion Molecules and Purine Metabolism in Alzheimer’s Disease , 2014, Molecular Neurobiology.

[37]  M. Esiri,et al.  Genome-wide profiling of alternative splicing in Alzheimer's disease , 2014, Genomics Data.

[38]  K. Lunetta,et al.  PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation , 2014, Annals of neurology.

[39]  Carlos Cruchaga,et al.  The epigenetic landscape of Alzheimer's disease , 2014, Nature Neuroscience.

[40]  D. Bennett,et al.  Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease , 2014, Nature Neuroscience.

[41]  Manolis Kellis,et al.  Alzheimery's disease pathology is associated with early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014, Nature Neuroscience.

[42]  J. Renger,et al.  Intracellular Clusterin Interacts with Brain Isoforms of the Bridging Integrator 1 and with the Microtubule-Associated Protein Tau in Alzheimer's Disease , 2014, PloS one.

[43]  Nick C Fox,et al.  Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease , 2014, PLoS ONE.

[44]  M. A. Alarcón,et al.  Overrepresentation of Glutamate Signaling in Alzheimer's Disease: Network-Based Pathway Enrichment Using Meta-Analysis of Genome-Wide Association Studies , 2014, PloS one.

[45]  D. Borchelt,et al.  Genetics of PICALM Expression and Alzheimer's Disease , 2014, PloS one.

[46]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[47]  L. Tan,et al.  Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease. , 2013, Trends in molecular medicine.

[48]  Chadwick M. Hales,et al.  U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s disease , 2013, Proceedings of the National Academy of Sciences.

[49]  Manasi Malik,et al.  CD33 Alzheimer's Risk-Altering Polymorphism, CD33 Expression, and Exon 2 Splicing , 2013, The Journal of Neuroscience.

[50]  J. Haines,et al.  Correction: SORL1 Is Genetically Associated with Late-Onset Alzheimer’s Disease in Japanese, Koreans and Caucasians , 2013, PLoS ONE.

[51]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[52]  J. D. Mills,et al.  RNA-Seq analysis of the parietal cortex in Alzheimer's disease reveals alternatively spliced isoforms related to lipid metabolism , 2013, Neuroscience Letters.

[53]  M. Owen,et al.  Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology , 2013, Molecular Psychiatry.

[54]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[55]  A. Hofman,et al.  Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.

[56]  A. Goate,et al.  Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease Brains , 2012, PloS one.

[57]  G. Breen,et al.  Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway , 2012, Molecular Psychiatry.

[58]  J. Haines,et al.  Identification and Confirmation of an Exonic Splicing Enhancer Variation in Exon 5 of the Alzheimer Disease Associated PICALM Gene , 2012, Annals of human genetics.

[59]  R. Cancedda,et al.  An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples , 2012, Disease Models & Mechanisms.

[60]  Margaret A. Pericak-Vance,et al.  Novel late-onset Alzheimer disease loci variants associate with brain gene expression , 2012, Neurology.

[61]  J. D. Mills,et al.  Alternative splicing of mRNA in the molecular pathology of neurodegenerative diseases , 2012, Neurobiology of Aging.

[62]  Michael W. Weiner,et al.  Genome-wide pathway analysis of memory impairment in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks , 2012, Brain Imaging and Behavior.

[63]  B Croisile,et al.  High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease , 2012, Molecular Psychiatry.

[64]  M Mancuso,et al.  Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease , 2012, Molecular Psychiatry.

[65]  N. Hübner,et al.  Identification of Alzheimer disease risk genotype that predicts efficiency of SORL1 expression in the brain. , 2012, Archives of Neurology.

[66]  Zugen Chen,et al.  Cell adhesion molecules contribute to Alzheimer’s disease: multiple pathway analyses of two genome‐wide association studies , 2012, Journal of neurochemistry.

[67]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[68]  M. Albert,et al.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[69]  Nick C Fox,et al.  Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.

[70]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[71]  J. Kril,et al.  Understanding the pathogenesis of Alzheimer’s disease: will RNA‐Seq realize the promise of transcriptomics? , 2011, Journal of neurochemistry.

[72]  E. Wijsman,et al.  Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE , 2011, PLoS genetics.

[73]  Weixiong Zhang,et al.  Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks , 2010, BMC Systems Biology.

[74]  Andrey Alexeyenko,et al.  Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease , 2010, Journal of Human Genetics.

[75]  Seth Love,et al.  Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease , 2010, PloS one.

[76]  Simon Heath,et al.  Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis. , 2010, Journal of Alzheimer's disease : JAD.

[77]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[78]  P. Bosco,et al.  Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.

[79]  Christoph Lange,et al.  Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.

[80]  J. Shendure.  The beginning of the end for microarrays? , 2008, Nature Methods.

[81]  B. Blencowe.  Alternative Splicing: New Insights from Global Analyses , 2006, Cell.

[82]  A. Levey,et al.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease. , 2004, Archives of neurology.

[83]  Christopher J. Lee,et al.  Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. , 2002, Nucleic acids research.

[84]  Alexander Meissner,et al.  Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. , 2015, JAMA neurology.

[85]  L. Tan,et al.  ABCA7 in Alzheimer’s Disease , 2014, Molecular Neurobiology.

[86]  P. S. St George-Hyslop,et al.  This month in archives of neurology. , 2012, Archives of neurology.

[87]  Nick C Fox,et al.  Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .

[88]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.